Michael Hubalek

Endocrine Therapy plus Zoledronic Acid in Premenopausal Breast Cancer

Michael Gnant, Brigitte Mlineritsch, Walter Schippinger et al. · New England Journal of Medicine · 2009 · 1K citations · Full text

Medicine, Oncology, Pharmacology +13

Adjuvant denosumab in breast cancer (ABCSG-18): a multicentre, randomised, double-blind, placebo-controlled trial

Michael Gnant, Georg Pfeiler, Peter Dubsky et al. · The Lancet · 2015 · 560 citations

Medicine, Oncology, Pharmacology +13

Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 62-month follow-up from the ABCSG-12 randomised trial

Michael Gnant, Brigitte Mlineritsch, Herbert Stoeger et al. · The Lancet Oncology · 2011 · 466 citations

Medicine, Oncology, Pharmacotherapy +17

hCDC4 gene mutations in endometrial cancer.

Charles Spruck, Heimo Strohmaier, Olle Sangfelt et al. · PubMed · 2002 · 274 citations

Life Sciences, Molecular Biology, Oncology +17

The PAM50 Risk-of-Recurrence Score Predicts Risk for Late Distant Recurrence after Endocrine Therapy in Postmenopausal Women with Endocrine-Responsive Early Breast Cancer

Martin Filipits, Torsten O. Nielsen, Margaretha Rudas et al. · Clinical Cancer Research · 2014 · 211 citations

Medicine, Biostatistics, Oncology +17